ACE and cancer: According to a large meta-analysis, angiotensin receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs), β-blockers, diuretics, and calcium channel blockers (CCBs) caused 5–10% cancer risk or cancer-related death (212).